CoChat

Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy

Colvin, Lyn, Slack‐Smith, Linda, Stanley, Fiona J., Bower, Carol · 2011 · Birth Defects Research Part A: Clinical and Molecular Teratology
Cited by 93

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The safety of selective serotonin reuptake inhibitors (SSRIs) during pregnancy remains uncertain. The purpose of this study was to investigate dispensing patterns and pregnancy outcomes for women dispensed an SSRI in pregnancy. METHODS: Using data linkage of population‐based health datasets from Western Australia and a national pharmaceutical claims dataset, our study included 123,405 pregnancies from 2002 to 2005. There were 3764 children born to 3703 women who were dispensed an SSRI during their pregnancy. RESULTS: A total of 42.3% of the women were dispensed an SSRI in each trimester, and 97.6% of the women used the same SSRI throughout the first trimester without switching. The women who were dispensed an SSRI were more likely to give birth prematurely (adjusted odds ratio [aOR], 1.4; 95% confidence interval [CI], 1.2–1.7), to have smoked during the pregnancy (OR, 1.9; 95% CI, 1.8–2.1), and parity >1 (OR, 1.7; 95% CI, 1.5–1.8). The singletons were found to have a lower birth weight than expected when other factors were taken into account (OR, 1.2; 95% CI, 1.1–1.3). There was an increased risk of major cardiovascular defects (OR, 1.6; 95% CI, 1.1–2.3). The children of women dispensed citalopram during the first trimester had an increased risk of vesicoureteric reflux (OR, 3.1; 95% CI, 1.3–7.6). Children born to women dispensed sertraline had a higher mean birth weight than those born to women dispensed citalopram, paroxetine, or fluoxetine. This pattern was also seen in birth length. CONCLUSIONS: Most women were dispensed the same SSRI throughout their pregnancy. We have confirmed previous findings with an increased risk of cardiovascular defects and preterm birth. New findings requiring confirmation include an increased risk of vesicoureteric reflux with the use of citalopram. Birth Defects Research (Part A), 2011. © 2011 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/bdra.20773

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 74

  1. 10.1097/AOG.0b013e31816fd910 · DOI · Paper page
  2. 10.1002/pds.1499 · DOI
  3. Australian Bureau of Statistics, 2006, Australian Historical Population Statistics, 2006
  4. Australian Bureau of Statistics, 2008, Socio‐Economic Indexes for Areas (SEIFA) – Technical Paper 2006
  5. Australian Drug Evaluation Committee, 1999, Prescribing medicines in pregnancy: an Australian categorisation of risk of drug use in pregnancy
  6. Australian Government Department of Health and Ageing, 2008, Schedule of Pharmaceutical Benefits
  7. Australian Institute of Health and Welfare, 2006, Australia's Health 2006
  8. 10.1002/pds.1964 · DOI
  9. 10.1002/bdrb.20099 · DOI · Paper page
  10. 10.1111/j.1365-3016.2004.00562.x · DOI · Paper page
  11. 10.1186/1471-2431-5-13 · DOI
  12. 10.1177/070674370404901103 · DOI · Paper page
  13. Bower C, 2009, Report of the Birth Defects Registry of Western Australia, 1980–2008
  14. 10.1002/bdra.20658 · DOI
  15. 10.1046/j.1440-1754.2000.00575.x · DOI
  16. 10.5694/j.1326-5377.1983.tb122403.x · doi:10.5694/j.1326-5377.1983.tb122403.x
  17. 10.1136/jech.52.11.740 · DOI
  18. British Paediatric Association, 1979, A paediatric supplement compatible with WHO International Classification of Diseases, 1977, 314
  19. 10.1056/NEJMoa052744 · DOI · Paper page
  20. 10.1056/NEJM199610033351402 · DOI · Paper page
  21. 10.1111/j.1530-0277.2006.00303.x · DOI · Paper page
  22. 10.1002/pds.1705 · DOI
  23. 10.1002/pds.1995 · DOI
  24. 10.1111/j.1365-2125.2008.03261.x · DOI · Paper page
  25. 10.1016/j.contraception.2006.08.002 · DOI
  26. 10.2147/CLEP.S9304 · DOI
  27. 10.1196/annals.1376.036 · DOI · Paper page
  28. 10.1007/s002280050664 · DOI · Paper page
  29. 10.1016/0163-6383(95)90003-9 · DOI · Paper page
  30. 10.3109/00207450802338697 · DOI · Paper page
  31. 10.1016/S0140-6736(06)68771-0 · DOI
  32. 10.1046/j.1365-2125.1998.00701.x · DOI · Paper page
  33. 10.1016/S0889-8545(05)70356-9 · DOI
  34. 10.1016/j.whi.2009.05.004 · DOI · Paper page
  35. Gaynes BN, 2005, Perinatal depression: prevalence, screening accuracy, and screening outcomes, Evid Rep Technol Assess (Summ), 119, 1
  36. 10.1111/j.1445-2197.2005.03412.x · doi:10.1111/j.1445-2197.2005.03412.x
  37. Gladstone J, 1997, Characteristics of pregnant women who engage in binge alcohol consumption, CMAJ, 156, 789
  38. 10.1067/mob.2003.172 · DOI · Paper page
  39. 10.1176/appi.ajp.160.5.993 · DOI · Paper page
  40. 10.1111/j.1467-842X.1999.tb01297.x · DOI · Paper page
  41. 10.1016/S0163-6383(98)90027-3 · DOI
  42. 10.1002/bdra.20327 · DOI · Paper page
  43. 10.5694/j.1326-5377.2007.tb00883.x · DOI
  44. 10.2147/CLEP.S9256 · DOI · Paper page
  45. 10.1001/jama.279.8.609 · DOI · Paper page
  46. 10.1053/j.semperi.2010.02.002 · DOI
  47. 10.1056/NEJMoa067407 · DOI · Paper page
  48. 10.1016/j.ijgo.2007.09.016 · DOI · Paper page
  49. 10.2165/00002018-199920020-00006 · DOI
  50. 10.1093/aje/kwm065 · doi:10.1093/aje/kwm065
  51. Mitchell AA, 2005, Pharmacoepidemiology, 501
  52. 10.1503/cmaj.091208 · DOI · Paper page
  53. 10.1053/j.semperi.2010.02.009 · DOI
  54. 10.1001/archpediatrics.2010.51 · DOI · Paper page
  55. 10.1001/archpsyc.63.8.898 · DOI · Paper page
  56. 10.1001/jama.1993.03500170076037 · DOI · Paper page
  57. 10.1136/bmj.b3569 · DOI · Paper page
  58. 10.1002/pds.1668 · doi:10.1002/pds.1668
  59. 10.1111/j.1471-0528.2007.01387.x · DOI · Paper page
  60. 10.1055/s-0028-1103296 · DOI · Paper page
  61. 10.1017/S0033291709992194 · DOI · Paper page
  62. 10.1176/appi.ajp.159.12.2055 · DOI · Paper page
  63. 10.1016/j.ajog.2005.05.012 · DOI
  64. 10.1111/j.1365-3016.1994.tb00482.x · DOI · Paper page
  65. 10.1176/appi.ajp.2007.06071172 · DOI · Paper page
  66. 10.2165/00003088-200443080-00001 · DOI · Paper page
  67. Therapeutic Goods Administration, 2005, Advice for women taking paroxetine intending to become pregnant or in early pregnancy, Australian Government Department of Health and Ageing
  68. 10.1097/JCP.0b013e3181bf344c · DOI · Paper page
  69. 10.1186/1472-6963-9-119 · DOI
  70. 10.1016/j.ajog.2006.02.019 · DOI · Paper page
  71. 10.1136/adc.2004.062422 · DOI
  72. 10.1002/da.20729 · DOI
  73. 10.1176/appi.ajp.2008.08081170 · DOI · Paper page
  74. 10.1097/01.ede.0000239581.76793.ae · DOI · Paper page

Cited by

See all 93

Metadata

Authors
Colvin, L., Slack‐Smith, L., Stanley, F. J., & Bower, C.
Venue
Birth Defects Research Part A: Clinical and Molecular Teratology
Publisher
Wiley
Published
2011-03
Volume
91
Issue
3
Pages
142-152
ISSN
  • 1542-0752 (ISSN-L)
  • 1542-0760
OpenAlex
W2106510144
Cited by
93
References
6
FWCI
10.58
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.